About Bard Geesaman
Bard Geesaman is a board member at NBO Pharma. The company is developing nasal octreotide for idiopathic intracranial hypertension.
He was Elixir Pharmaceuticals' vice president of medical development from 2003 to 2007. He later founded Solasia Pharma. From 2012 to 2015, he was the X PRIZE Foundation's life sciences executive director. By 2015, he had been an MPM managing director since January 2012. He joined Chiasma's board in 2004. In 2015, he was a general partner at F2 and F3 Ventures and had served on their boards since 2004.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Bard Geesaman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bard Geesaman works with at each company, as listed on that company's latest Form D.